Filing Flows

Filing Flows › Companies › VitaNova Life Sciences › Cash flow

VitaNova Life Sciences cash flow, quarter by quarter

Latest: Q1 FY27 · from the cash-flow statements filed with the SEC

Free cash flow$7K in Q1 FY27 · $558K over twelve months

Operating cash flow$7K
Free cash flow+$7K
Cash conversion cycle161 days

Analysis

In Q1 FY27, VitaNova Life Sciences generated $7K of operating cash flow. That is $257K less than in Q1 FY26 ($264K).

Over the twelve months to Jul 31, 2026, operating cash flow was $558K; the cash balance rose by $558K.

Operating cash flow was $7K against net income of −$123K. The largest differences: receivables +$410K, inventory −$196K, payables −$86K.

Its cash conversion cycle was 161 days (receivables 149 + inventory 64 − payables 52).

Free cash flow

VitaNova Life Sciences: free cash flow by quarterVitaNova Life Sciences: free cash flow by quarter$9KQ2 FY25$209KQ3 FY25$479KQ4 FY25$264KQ1 FY26$213KQ2 FY26−$90KQ3 FY26$428KQ4 FY26$7KQ1 FY27
Operating cash flow less capital spending.
VitaNova Life Sciences: operating cash flow against capital spendingVitaNova Life Sciences: operating cash flow against capital spendingOperating cash flowCapital spending$9K$0Q2 FY25$209K$0Q3 FY25$479K$0Q4 FY25$264K$0Q1 FY26$213K$0Q2 FY26−$90K$0Q3 FY26$428K$0Q4 FY26$7K$0Q1 FY27
Latest (Q1 FY27): Operating cash flow $7K, Capital spending $0.

Capital allocation, year by year

VitaNova Life Sciences: where the cash came from (up) and went (down), by fiscal yearVitaNova Life Sciences: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingFY22: Operating cash flow $4K$4KFY22FY23: Operating cash flow −$18KFY23FY24: Operating cash flow −$376KFY24: Net borrowing $3K$3KFY24FY25: Operating cash flow $193KFY25: Net borrowing −$3K$193KFY25FY26: Operating cash flow $814K$814KFY26
Over these 5 years operating cash flow totalled $617K; the largest uses were operating cash flow ($394K) and net borrowing ($3K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$1.6M
Debtnone
Net cash$1.6M

VitaNova Life Sciences funds itself: free cash flow was $558K over the last twelve months, with $1.6M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

VitaNova Life Sciences: sources (+) and uses (−) of cash, Q1 FY27VitaNova Life Sciences: sources (+) and uses (−) of cash, Q1 FY27Operating cash flow$7KCash drawn (+) / kept (−)−$7K
VitaNova Life Sciences: sources (+) and uses (−) of cash, TTM to Q1 FY27VitaNova Life Sciences: sources (+) and uses (−) of cash, TTM to Q1 FY27Operating cash flow$558KCash drawn (+) / kept (−)−$558K

From profit to cash

VitaNova Life Sciences: net income to operating cash flow, Q1 FY27VitaNova Life Sciences: net income to operating cash flow, Q1 FY27Net income−$123KReceivables$410KInventory−$196KPayables−$86KIncome taxes payable$1KOperating cash flow$7K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q1 FY271496452161
Q4 FY26437941
Q3 FY261221732106
Q1 FY26101070167913
Q3 FY251718955151

Every quarter

QuarterOperating cash flowCash drawn (+) / kept (−)Free cash flow
Q1 FY27$7K−$7K$7K
Q4 FY26$428K−$428K$428K
Q3 FY26−$90K$90K−$90K
Q2 FY26$213K−$213K$213K
Q1 FY26$264K−$264K$264K
Q4 FY25$479K−$378K$479K
Q3 FY25$209K−$182K$209K
Q2 FY25$9K−$81K$9K

VitaNova Life Sciences: income statement and cash flow

VitaNova Life Sciences, Q1 FY27: revenue $322K (+210% year over year), operating margin -38.0%. The chart follows the revenue to costs, profit and cash.

VitaNova Life Sciences: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.